Patent US4880804A successfully refreshed from Google Patents.
US4880804A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Angiotensin II receptor blocking benzimidazoles
Assignee: EIDP Inc
•
Filing: 1988-01-07
•
Granted: 1989-11-14
•
Expires: 2008-01-07
Abstract
Abstract Substituted benzimidazoles such as <IMAGE> and pharmaceutically suitable salts thereof are useful as angiotensin II blockers. These compounds have activity in treating hypertension and congestive heart failure.
Inventors
- 👤 David J. Carini
- 👤 John Jonas V. Duncia
- 👤 Sung-eun Yoo
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 09:12
CPC Classifications
C; C07; C07D; C07D403/00; C07D403/02; C07D403/12; C07D235/00; C07D235/02; C07D235/04; C07D235/06; C07D235/08; C07D235/16
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
453 words
A compound of the formula ##STR74## where R 1 is --CO 2 H, --NHSO 2 CF 3 , ##STR75## R 2 is H, halogen, NO 2 , methoxy, or alkyl of 1 to 4 carbon atoms; R 3 is alkyl of 1 to 6 carbon atoms, alkenyl or alkynyl of 3 to 6 carbon atoms each of which may be unsubstituted or substituted with a halogen atom, --OR 4 or up to two --CO 2 R 4 ; with the proviso that when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; R 4 is H, or alkyl of 1-4 carbon atoms; R 5 is H, alkyl of 1 to 5 carbon atoms, cycoalkyl of 3 to 6 carbon atoms, (CH 2 ) m C 6 H 5 , OR 6 , or NR 7 R 8 ; R 6 H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms or phenyl; R 7 and R 8 independently are H, alkyl of 1 to 4 carbon atoms, phenyl, benzyl or taken together with nitrogen form a ring of the formula ##STR76## Q is NR 9 , O, or CH 2 ; R 9 is H, alkyl of 1 to 4 carbon atoms, or phenyl; R 10 is alkyl of 1 to 6 carbon atoms; A is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen, alkoxy of 1 to 6 carbon atoms; ##STR77## B is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen or alkoxy of 1 to 6 carbon atoms; X is a carbon-carbon single bond, --CO--, --O--, --NHCO--, or --OCH 2 --; n is 1 to 6; m is 0 to 3; p is 0 or 1; or a pharmaceutically acceptable salt thereof; provided that: (1) when R 3 is methyl is must be substituted with --OR 4 or CO 2 R 4 ; (2) when R 3 is --CH═CH--CO 2 Et, then X is not --NHCO; (3) when R 3 is CH 2 OH, CH=CHCO 2 H or CH 2 CH 2 CO 2 H and A and B are hydrogen, then X cannot be a carbon-carbon single bond; (4) when R 1 is --CO 2 H, R 3 is butyl, and X is a carbon-carbon single bond, then A is not 5-Cl; (5) when R 1 is --CO 2 H, R 3 is CH 2 OCH 3 and X is a carbon-carbon single bond, then A is not 5-CH 2 OH; (6) when R 1 is --CO 2 H, X is not --O--.
Claim 2
Dependent Claim
453 words
A compound of the formula ##STR74## where R 1 is --CO 2 H, --NHSO 2 CF 3 , ##STR75## R 2 is H, halogen, NO 2 , methoxy, or alkyl of 1 to 4 carbon atoms; R 3 is alkyl of 1 to 6 carbon atoms, alkenyl or alkynyl of 3 to 6 carbon atoms each of which may be unsubstituted or substituted with a halogen atom, --OR 4 or up to two --CO 2 R 4 ; with the proviso that when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; R 4 is H, or alkyl of 1-4 carbon atoms; R 5 is H, alkyl of 1 to 5 carbon atoms, cycoalkyl of 3 to 6 carbon atoms, (CH 2 ) m C 6 H 5 , OR 6 , or NR 7 R 8 ; R 6 H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms or phenyl; R 7 and R 8 independently are H, alkyl of 1 to 4 carbon atoms, phenyl, benzyl or taken together with nitrogen form a ring of the formula ##STR76## Q is NR 9 , O, or CH 2 ; R 9 is H, alkyl of 1 to 4 carbon atoms, or phenyl; R 10 is alkyl of 1 to 6 carbon atoms; A is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen, alkoxy of 1 to 6 carbon atoms; ##STR77## B is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen or alkoxy of 1 to 6 carbon atoms; X is a carbon-carbon single bond, --CO--, --O--, --NHCO--, or --OCH 2 --; n is 1 to 6; m is 0 to 3; p is 0 or 1; or a pharmaceutically acceptable salt thereof; provided that: (1) when R 3 is methyl is must be substituted with --OR 4 or CO 2 R 4 ; (2) when R 3 is --CH═CH--CO 2 Et, then X is not --NHCO; (3) when R 3 is CH 2 OH, CH=CHCO 2 H or CH 2 CH 2 CO 2 H and A and B are hydrogen, then X cannot be a carbon-carbon single bond; (4) when R 1 is --CO 2 H, R 3 is butyl, and X is a carbon-carbon single bond, then A is not 5-Cl; (5) when R 1 is --CO 2 H, R 3 is CH 2 OCH 3 and X is a carbon-carbon single bond, then A is not 5-CH 2 OH; (6) when R 1 is --CO 2 H, X is not --O--.
Claim 3
Dependent Claim
108 words
Compound of claim 1 wherein R 1 is --CO 2 H, --NHSO 2 CF 3 ; or ##STR78## R 2 is hydrogen; R 3 is alkyl of 3 to 6 carbon atoms, alkenyl or alkynyl of 3 to 6 carbon atoms each of which may be unsubstituted or substituted with --OR 4 or CO 2 R 4 ; R 5 is H, alkyl of 1 to 5 carbon atoms, OR 6 or NR 7 R 8 ; R 6 is H, alkyl of 1 to 5 carbon atoms; A is halogen, alkoxy of 1 to 6 carbon atoms; ##STR79## B is H; or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim
64 words
Compound of claim 2 wherein R 3 is alkyl of 3 to 5 carbon atoms, alkenyl or akynyl of 3 to 5 carbon atoms each of which may be unsubstituted or substituted with OH, OCH 3 , CO 2 H or CO 2 CH 3 ; ##STR80## n is 1-2; X is a carbon-carbon single bond, or --NHCO--; or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim
13 words
Compound of claim 1 which is 2-butyl-1[(2'-carboxybiphenyl-4-yl)methyl]-6-hydroxymethyl-benzimidazole, or a pharmaceutically suitable salt thereof.
Claim 6
Dependent Claim
13 words
Compound of claim 1 which is 2-butyl-1-[(2'-carboxybiphenyl-4-yl)methyl]-5-hydroxymethyl-benzimidazole, or a pharmaceutically suitable salt thereof.
Claim 7
Dependent Claim
13 words
Compound of claim 1 which is 2-butyl-1-[2'-carboxybiphenyl-4-yl)methyl]-6-methoxybenzimidazole, or a pharmaceutically suitable salt thereof.
Claim 8
Dependent Claim
13 words
Compound of claim 1 which is 2-(1-butenyl)-1[(2'-carboxybiphenyl-4-yl)-methyl]-6-hydroxymethylbenzimidazole, or a pharmaceutically suitable salt thereof.
Claim 9
Dependent Claim
13 words
Compound of claim 1 which is 2-butyl-1-[(2'-carboxybiphenyl-4-yl)methyl]-6-chlorobenzimidazole, or a pharmaceutically suitable salt thereof.
Claim 10
Dependent Claim
44 words
Pharmaceutical composition useful for treating hypertension or congestive heart failure in a warm-blooded animal comprising a suitable pharmaceutical carrier and a compound of any one of claims 1 through 8 in an amount effective to lower the animal's blood pressure or relieve the congestion.
Claim 11
Dependent Claim
33 words
Method of treating hypertension in a warm-blooded animal comprising administering to the animal in an amount effective to lower the animal's blood pressure a compound of any one of claims 1 through 8.
Claim 12
Dependent Claim
41 words
Method of treating congestive heart failure in a warm-blooded animal comprising administering to the animal a compound of any one of claims 1 through 8 in an amount effective to correct the hemodynamic burden on the heart to relieve the congestion.
Claim 13
Dependent Claim
465 words
Method of treating hypertension in a warm-blooded animal comprising administering to the animal in an amount effective to lower the animal's blood pressure a compound of the formula: ##STR81## where R 1 is --CO 2 H, --NHSO 2 CF 3 , ##STR82## R 2 is H, halogen, NO 2 , methoxy, or alkyl of 1 to 4 carbon atoms; R 3 is alkyl of 1 to 6 carbon atoms, alkenyl or alkynyl of 3 to 6 carbon atoms each of which may be unsubstituted or substituted with a halogen atom, --OR 4 or up to two --CO 2 R 4 ; with the proviso that when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; R 4 is H, or alkyl of 1-4 carbon atoms; R 5 is H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, (CH 2 ) m C 6 H 5 , OR 6 , or NR 7 R 8 ; R 6 is H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms or phenyl; R 7 and R 8 independently are H, alkyl of 1 to 4 carbon atoms, phenyl, benzyl or taken together with nitrogen form a ring of the formula ##STR83## Q is NR 9 , O, or CH 2 ; R 9 is H, alkyl of 1 to 4 carbon atoms, or phenyl; R 10 is alkyl of 1 to 6 carbon atoms; A is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen, alkoxy of 1 to 6 carbon atoms; ##STR84## B is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen or alkoxy of 1 to 6 carbon atoms; X is a carbon-carbon single bond, --CO--, --O--, --NHCO--, or --OCH 2 --; n is 1 to 6; m is 0 to 3; p is 0 or 1; or a pharmaceutically acceptable salt thereof; provided that: (1) when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; (2) when R 3 is --CH═CH--CO 2 Et, then X is not --NHCO; (3) when R 3 is CH 2 OH, CH=CHCO 2 H or CH 2 CH 2 CO 2 H and A and B are hydrogen, then X cannot be a carbon-carbon single bond; (4) when R 1 is --CO 2 H, R 3 is butyl, and X is a carbon-carbon single bond, then A is not 5-Cl; (5) when R 1 is --CO 2 H, R 3 is CH 2 OCH 3 and X is a carbon-carbon single bond, then A is not 5-CH 2 OH.
Claim 14
Dependent Claim
465 words
Method of treating hypertension in a warm-blooded animal comprising administering to the animal in an amount effective to lower the animal's blood pressure a compound of the formula: ##STR81## where R 1 is --CO 2 H, --NHSO 2 CF 3 , ##STR82## R 2 is H, halogen, NO 2 , methoxy, or alkyl of 1 to 4 carbon atoms; R 3 is alkyl of 1 to 6 carbon atoms, alkenyl or alkynyl of 3 to 6 carbon atoms each of which may be unsubstituted or substituted with a halogen atom, --OR 4 or up to two --CO 2 R 4 ; with the proviso that when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; R 4 is H, or alkyl of 1-4 carbon atoms; R 5 is H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, (CH 2 ) m C 6 H 5 , OR 6 , or NR 7 R 8 ; R 6 is H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms or phenyl; R 7 and R 8 independently are H, alkyl of 1 to 4 carbon atoms, phenyl, benzyl or taken together with nitrogen form a ring of the formula ##STR83## Q is NR 9 , O, or CH 2 ; R 9 is H, alkyl of 1 to 4 carbon atoms, or phenyl; R 10 is alkyl of 1 to 6 carbon atoms; A is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen, alkoxy of 1 to 6 carbon atoms; ##STR84## B is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen or alkoxy of 1 to 6 carbon atoms; X is a carbon-carbon single bond, --CO--, --O--, --NHCO--, or --OCH 2 --; n is 1 to 6; m is 0 to 3; p is 0 or 1; or a pharmaceutically acceptable salt thereof; provided that: (1) when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; (2) when R 3 is --CH═CH--CO 2 Et, then X is not --NHCO; (3) when R 3 is CH 2 OH, CH=CHCO 2 H or CH 2 CH 2 CO 2 H and A and B are hydrogen, then X cannot be a carbon-carbon single bond; (4) when R 1 is --CO 2 H, R 3 is butyl, and X is a carbon-carbon single bond, then A is not 5-Cl; (5) when R 1 is --CO 2 H, R 3 is CH 2 OCH 3 and X is a carbon-carbon single bond, then A is not 5-CH 2 OH.
Claim 15
Dependent Claim
471 words
Method of treating congestive heart failure in warm-blooded animals comprising administering to the animal a compound of the formula: ##STR85## where R 1 is --CO 2 H, --NHSO 2 CF 3 , ##STR86## R 2 is H, halogen, NO 2 , methoxy, or alkyl of 1 to 4 carbon atoms; R 3 is alkyl of 1 to 6 carbon atoms, alkenyl or alkynyl of 3 to 6 carbon atoms each of which may be unsubstituted or substituted with a halogen atom, --OR 4 or up to two --CO 2 R 4 ; with the proviso that when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; R 4 is H, or alkyl of 1-4 carbon atoms; R 5 is H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, (CH 2 ) m C 6 H 5 , OR 6 , or NR 7 R 8 ; R 6 H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms or phenyl; R 7 and R 8 independently are H, alkyl of 1 to 4 carbon atoms, phenyl, benzyl or taken together with nitrogen form a ring of the formula ##STR87## Q is NR 9 , O, or CH 2 ; R 9 is H, alkyl of 1 to 4 carbon atoms, or phenyl; R 10 is alkyl of 1 to 6 carbon atoms; A is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen, alkoxy of 1 to 6 carbon atoms; ##STR88## B is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen or alkoxy of 1 to 6 carbon atoms; X is a carbon-carbon single bond, --CO--, --O--, --NHCO--, or --OCH 2 --; n is 1 to 6; m is 0 to 3; p is 0 or 1; or a pharmaceutically acceptable salt thereof in an amount effective to correct the hemodynamic burden on the heart to relieve the congestion; provided that: (1) when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; (2) when R 3 is --CH=CH--CO 2 Et, then X is not --NHCO; (3) when R 3 is CH 2 OH, CH=CHCO 2 H or CH 2 CH 2 CO 2 H and A and B are hydrogen, then X cannot be a carbon-carbon single bond; (4) when R 1 is --CO 2 H, R 3 is butyl, and X is a carbon-carbon single bond, then A is not 5-Cl; (5) when R 1 is --CO 2 H, R 3 is CH 2 OCH 3 and X is a carbon-carbon single bond, then A is not 5-CH 2 OH.
Claim 16
Dependent Claim
471 words
Method of treating congestive heart failure in warm-blooded animals comprising administering to the animal a compound of the formula: ##STR85## where R 1 is --CO 2 H, --NHSO 2 CF 3 , ##STR86## R 2 is H, halogen, NO 2 , methoxy, or alkyl of 1 to 4 carbon atoms; R 3 is alkyl of 1 to 6 carbon atoms, alkenyl or alkynyl of 3 to 6 carbon atoms each of which may be unsubstituted or substituted with a halogen atom, --OR 4 or up to two --CO 2 R 4 ; with the proviso that when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; R 4 is H, or alkyl of 1-4 carbon atoms; R 5 is H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, (CH 2 ) m C 6 H 5 , OR 6 , or NR 7 R 8 ; R 6 H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms or phenyl; R 7 and R 8 independently are H, alkyl of 1 to 4 carbon atoms, phenyl, benzyl or taken together with nitrogen form a ring of the formula ##STR87## Q is NR 9 , O, or CH 2 ; R 9 is H, alkyl of 1 to 4 carbon atoms, or phenyl; R 10 is alkyl of 1 to 6 carbon atoms; A is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen, alkoxy of 1 to 6 carbon atoms; ##STR88## B is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen or alkoxy of 1 to 6 carbon atoms; X is a carbon-carbon single bond, --CO--, --O--, --NHCO--, or --OCH 2 --; n is 1 to 6; m is 0 to 3; p is 0 or 1; or a pharmaceutically acceptable salt thereof in an amount effective to correct the hemodynamic burden on the heart to relieve the congestion; provided that: (1) when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; (2) when R 3 is --CH=CH--CO 2 Et, then X is not --NHCO; (3) when R 3 is CH 2 OH, CH=CHCO 2 H or CH 2 CH 2 CO 2 H and A and B are hydrogen, then X cannot be a carbon-carbon single bond; (4) when R 1 is --CO 2 H, R 3 is butyl, and X is a carbon-carbon single bond, then A is not 5-Cl; (5) when R 1 is --CO 2 H, R 3 is CH 2 OCH 3 and X is a carbon-carbon single bond, then A is not 5-CH 2 OH.
References Cited (Backward Citations)
US3821393A
Cited
US3772315A
Cited
US4347365A
Cited
US4207324A
Cited
US4347364A
Cited
US4226878A
Cited
US4448781A
Cited
US4463011A
Cited
US4340598A
Cited
US4355040A
Cited
US4328349A
Cited
US4379927A
Cited
EP0103647A1
Cited
EP0090978A2
Cited
EP0125033A1
Cited
EP0125783A1
Cited
US4612323A
Cited
EP0146228A1
Cited
DE3426018A1
Cited
DE3426195A1
Cited
US4663339A
Cited
JPH08298270A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-11-13 | 1993-05-15 | 1993-11-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-11-13 | 1997-05-15 | 1997-11-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-11-13 | 2001-05-15 | 2001-11-14 | $7700.00 | Window Closed / Lapsed |